Tag: BCLI stock

In the past week, BCLI stock has gone down by -8.04%, with a monthly gain of 49.20% and a quarterly surge of 79.29%. The volatility

Brainstorm Cell Therapeutics, Inc. (NASDAQ: BCLI) has experienced a rise in its stock price by 31.03 compared to its previous closing price of 0.56. However,

In the past week, BCLI stock has gone up by 99.45%, with a monthly gain of 87.68% and a quarterly surge of 239.38%. The volatility

The 36-month beta value for BCLI is also noteworthy at 0.24. There are mixed opinions on the stock, with 1 analysts rating it as a

Company’s 36-month beta value is 0.21.Analysts have differing opinions on the stock, with 1 analysts rating it as a “buy,” 0 as “overweight,” 0 as